---
name: Porton Advanced
slug: porton-advanced
site: cdmo
website_domain: portonadvanced.com
summary: End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe. Headquartered in Suzhou, China.
tagline: End-to-end ATMP CDMO from cell banking to commercial manufacturing
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: Porton Pharma Solutions
parent_slug: portonpharmasolutions
hq_country: CN
tier2_domain_verified: false
updated_at: 2026-08-08T00:03:20.538Z
services_count: 14
modalities_count: 4
indications_count: 0
locations_count: 18
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Porton Advanced

End-to-end ATMP CDMO from cell banking to commercial manufacturing

Listed on cdmo.directory.

## Summary

End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe. Headquartered in Suzhou, China.

## At a glance

- Parent: [Porton Pharma Solutions](/companies/portonpharmasolutions)
- HQ country: CN

## Services

- Cell-Line Development
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Lentiviral Vector Manufacturing
- AAV Manufacturing
- Viral Vector Manufacturing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- CMC Analytical Development
- Process Development
- Technology Transfer
- CMC Regulatory Submission Support
- Sterile Fill-Finish & Aseptic Manufacturing

## Modalities

- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
- mRNA

## Locations

- Ascendas Park Campus, Suzhou, Jiangsu, China
- Sangtiandao Campus, Suzhou, Jiangsu, China
- Cranbury Campus, Cranbury, New Jersey, United States
- Chongqing Beibei R&D Site, Chongqing, Chongqing, China
- Chongqing Changshou Manufacturing Site, Chongqing, Chongqing, China
- Chongqing Beibei Manufacturing Site, Chongqing, Chongqing, China
- Shanghai Minhang R&D Site, Shanghai, Shanghai, China
- Shanghai Fengxian Manufacturing Site, Shanghai, Shanghai, China
- Shanghai Pudong R&D and Manufacturing Site, Shanghai, Shanghai, China
- Jiangxi Yichun Manufacturing Site, Yichun, Jiangxi, China
- Hubei Xiaogan Manufacturing Site, Xiaogan, Hubei, China
- J-STAR South Plainfield R&D Site, South Plainfield, New Jersey, United States
- J-STAR Cranbury R&D Site, Cranbury, New Jersey, United States
- Porton Advanced Shipping/Logistic Center, Cranbury, New Jersey, United States
- Copenhagen Office, Copenhagen, Copenhagen, Denmark
- Turnhout Office, Turnhout, Turnhout, Belgium
- Slovenia R&D and Manufacturing Site, Ljubljana, Ljubljana, Slovenia
- Root Office, Root, Root, Switzerland

## Long description

Porton Advanced is a specialized CDMO focused on Advanced Therapy Medicinal Products (ATMPs), providing integrated services from early research through commercial manufacturing. Core capabilities include:

**Cell Engineering & Gene Therapy:**
- CAR-T, TCR-T, and CAR-NK cell therapy manufacturing
- Autologous and allogeneic cell engineering
- iPSC-derived cell therapies
- MSC cell therapy

**Viral Vectors & Nucleic Acids:**
- Lentiviral vector manufacturing and GMP production
- Adeno-associated viral (AAV) vector development with proprietary AAVantage® capsid library platform
- mRNA and lipid nanoparticle (LNP) formulation and manufacturing
- Plasmid development (supercoiled, linear, LcDNA)
- Vector construction and plasmid preparation services

**CMC & Analytical Services:**
- Process and analytical method development
- Cell banking and characterization
- GMP manufacturing for drug substance (DS) and drug product (DP)
- Investigator-initiated clinical trial (IIT) support with integrated clinical data collection and analysis

**Regulatory Track Record:**
- 24 IND approvals across NMPA (17), FDA (6), and MedSafe (1)
- 100% submission success rate
- 400+ GMP batches manufactured
- 30+ IIT projects completed

**Global Manufacturing Footprint:**
Multiple GMP-compliant facilities across China (Suzhou, Chongqing, Shanghai, Jiangxi, Hubei), United States (New Jersey), and Europe (Denmark, Belgium, Slovenia, Switzerland) supporting DS and DP manufacturing.

## Related companies

- [Aldevron](/companies/aldevron) (Cell-Line Development, Cell Therapy Manufacturing) — [Compare](/compare/aldevron/porton-advanced)
- [Cell and Gene Therapy Catapult](/companies/ct) (Cell-Line Development, Cell Therapy Manufacturing) — [Compare](/compare/ct/porton-advanced)
- [Andelyn Biosciences](/companies/andelynbio) (Cell-Line Development, Cell Therapy Manufacturing) — [Compare](/compare/andelynbio/porton-advanced)
- [ElevateBio](/companies/elevate) (Cell-Line Development, Cell Therapy Manufacturing) — [Compare](/compare/elevate/porton-advanced)
- [Oxford Biomedica](/companies/oxb) (Cell Therapy Manufacturing, Lentiviral Vector Manufacturing) — [Compare](/compare/oxb/porton-advanced)
- [Pluri](/companies/pluri-biotech) (Cell-Line Development, Cell Therapy Manufacturing) — [Compare](/compare/pluri-biotech/porton-advanced)
- [Biomay AG](/companies/biomay) (Cell-Line Development, mRNA Manufacturing) — [Compare](/compare/biomay/porton-advanced)
- [WuXi Advanced Therapies](/companies/advancedtherapies) (Cell-Line Development, Cell Therapy Manufacturing) — [Compare](/compare/advancedtherapies/porton-advanced)

_Profile last updated: 2026-08-08T00:03:20.538Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.